Glen Eagle Advisors’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-5
| Closed | -$1.09K | – | 1067 |
|
|
2023
Q2 | $1.09K | Hold |
5
| – | – | ﹤0.01% | 951 |
|
|
2023
Q1 | $1.1K | Hold |
5
| – | – | ﹤0.01% | 945 |
|
|
2022
Q4 | $1.04K | Hold |
5
| – | – | ﹤0.01% | 1012 |
|
|
2022
Q3 | $1.09K | Hold |
5
| – | – | ﹤0.01% | 963 |
|
|
2022
Q2 | $1.05K | Hold |
5
| – | – | ﹤0.01% | 898 |
|
|
2022
Q1 | $1.21K | Hold |
5
| – | – | ﹤0.01% | 858 |
|
|
2021
Q4 | $1.3K | Hold |
5
| – | – | ﹤0.01% | 848 |
|
|
2021
Q3 | $1.32K | Buy |
+5
| New | +$1.32K | ﹤0.01% | 972 |
|
|
2020
Q2 | – | Sell |
-2
| Closed | -$295 | – | 932 |
|
|
2020
Q1 | $295 | Hold |
2
| – | – | ﹤0.01% | 809 |
|
|
2019
Q4 | $310 | Hold |
2
| – | – | ﹤0.01% | 878 |
|
|
2019
Q3 | $270 | Hold |
2
| – | – | ﹤0.01% | 803 |
|
|
2019
Q2 | $244 | Buy |
+2
| New | +$244 | ﹤0.01% | 780 |
|